, Agreement between the European Community and the Swiss Confederation on trade in agricul…

In forcesince 1 Sep 2026
1.

Inspections shall be carried out under the responsibility of the Joint Veterinary Committee in accordance in particular with Article 116 of Regulation (EU) 2017/625 and Article 57 of the Law on epizootic diseases.

2.

Animals traded between the Member States of the European Union and Switzerland shall move under the same conditions as animals traded between the Member States of the European Union. Where necessary, these products shall be accompanied by the health certificates required for trade between the Member States of the European Union and available in the TRACES system.

3.

For the purposes of this Annex, Switzerland is recognised as fulfilling the conditions provided for in Chapter 4 of Part II of Regulation (EU) 2016/429, Commission Delegated Regulation (EU) 2020/689 [Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases (OJ L 174, 3.6.2020, p. 211, ELI: http://data.europa.eu/eli/reg_del/2020/689/oj).] and Commission Implementing Regulation (EU) 2021/620 [Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (OJ L 131, 16.4.2021, p. 78, ELI: http://data.europa.eu/eli/reg_impl/2021/620/oj).] as regards the diseases listed in the sites of the Commission ‘Surveillance, eradication programmes and disease-free status – Food Safety’ and of the Federal Food Safety and Veterinary Office ‘National Surveillance Programme’.

For diseases for which Switzerland does not yet have approval of disease-free status, Switzerland shall present to the Joint Veterinary Committee the information necessary to obtain that status according to the approval criteria set out in Regulation (EU) 2016/429. On the basis of this information, the Joint Veterinary Committee agrees to update the information available on the websites mentioned above.

The Federal Food Safety and Veterinary Office shall immediately notify the Commission of any change in the conditions on which recognition of that status is based for one of the diseases listed in this paragraph. The situation shall be examined within the Joint Veterinary Committee.

4.

Switzerland shall apply the same provisions as those of Article 107 (with the exception of paragraph 6) of Regulation (EU) 2019/6, in conjunction with Article 37(5) thereof on the use of antimicrobial medicinal products in animals intended for production, in accordance with its legislation listed in Section A above.

Switzerland does not authorise either the placing on the market of medicinal products intended for production animals containing one of the antimicrobials or groups of antimicrobials listed in point (2) or (3) of the Annex to Commission Implementing Regulation (EU) 2022/1255 [Commission Implementing Regulation (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for the treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (OJ L 191, 20.7.2022, p. 58, ELI: http://data.europa.eu/eli/reg_impl/2022/1255/oj).] or the use in production animals of medicinal products for human use containing these antimicrobials or groups of antimicrobials.

Discussions will take place in the Joint Veterinary Committee on amendments to the above-mentioned European Union legislation requiring adaptation of the Swiss provisions.

Therefore, Switzerland shall not be considered as a third country for the purposes of Article 118 of Regulation (EU) 2019/6 until 1 July 2028.

It shall immediately inform the Joint Veterinary Committee of any further changes to its legislation on antimicrobial medicinal products intended for production animals.

This paragraph shall be reviewed by the Joint Veterinary Committee before 1 July 2028.